Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (372)
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
346,836
Price
$5.89
Total Value
$2.04M
Shares Held After
3,768,872
% of Holdings
8.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
881
Price
$192.61
Total Value
$169.69K
Shares Held After
21,656
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
541
Price
$191.87
Total Value
$103.80K
Shares Held After
22,537
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
600
Price
$190.54
Total Value
$114.33K
Shares Held After
23,078
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
100
Price
$188.57
Total Value
$18.86K
Shares Held After
23,678
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$187.83
Total Value
$56.35K
Shares Held After
23,778
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
858
Price
$186.92
Total Value
$160.37K
Shares Held After
24,078
% of Holdings
3.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
1,100
Price
$185.90
Total Value
$204.49K
Shares Held After
24,936
% of Holdings
4.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
900
Price
$184.59
Total Value
$166.13K
Shares Held After
26,036
% of Holdings
3.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$183.17
Total Value
$54.95K
Shares Held After
26,936
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
28,571
Price
$5.78
Total Value
$165.14K
Shares Held After
525,964
% of Holdings
5.2%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
350
Price
$6.00
Total Value
$2.10K
Shares Held After
3,601,143
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
18,060
Price
$5.87
Total Value
$105.96K
Shares Held After
3,601,493
% of Holdings
0.5%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
11,579
Price
$35.91
Total Value
$415.82K
Shares Held After
1,047,205
% of Holdings
1.1%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
13,421
Price
$35.13
Total Value
$471.53K
Shares Held After
1,058,784
% of Holdings
1.3%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
876
Price
$40.34
Total Value
$35.34K
Shares Held After
548,027
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7,344
Price
$39.77
Total Value
$292.06K
Shares Held After
548,903
% of Holdings
1.3%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
95,722
Price
$9.01
Total Value
$862.22K
Shares Held After
0
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
5,500
Price
$123.51
Total Value
$679.30K
Shares Held After
58,117
% of Holdings
8.6%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
FOSTER JAMES C — Director
Shares
75,000
Price
$225.00
Total Value
$16.88M
Shares Held After
31,596
% of Holdings
70.4%
Akebia Therapeutics, Inc. (AKBA)
Ostrowski Erik — SVP, CFO, CBO & Treasurer
Shares
56,019
Price
$1.11
Total Value
$62.18K
Shares Held After
616,616
% of Holdings
8.3%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$10.02
Total Value
$70.15K
Shares Held After
83,865
% of Holdings
7.7%
Candel Therapeutics, Inc. (CADL)
Barone Francesca — Chief Scientific Officer
Shares
23,447
Price
$10.06
Total Value
$235.77K
Shares Held After
77,362
% of Holdings
23.3%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
58,926
Price
$30.08
Total Value
$1.77M
Shares Held After
8,375,814
% of Holdings
0.7%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
555,826
Price
$29.17
Total Value
$16.21M
Shares Held After
8,434,740
% of Holdings
6.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
36,520
Price
$59.23
Total Value
$2.16M
Shares Held After
15,390,469
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
8,320
Price
$58.30
Total Value
$485.06K
Shares Held After
15,426,989
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
41,178
Price
$57.13
Total Value
$2.35M
Shares Held After
15,435,309
% of Holdings
0.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
37,711
Price
$56.51
Total Value
$2.13M
Shares Held After
15,476,487
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,271
Price
$55.38
Total Value
$513.43K
Shares Held After
15,514,198
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,130
Price
$59.23
Total Value
$540.77K
Shares Held After
8,775,283
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
2,080
Price
$58.30
Total Value
$121.26K
Shares Held After
8,784,413
% of Holdings
0.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
10,293
Price
$57.13
Total Value
$588.04K
Shares Held After
8,786,493
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,430
Price
$56.51
Total Value
$532.89K
Shares Held After
8,796,786
% of Holdings
0.1%
Protara Therapeutics, Inc. (TARA)
Shefferman Jesse — Director
Shares
215,687
Price
$4.09
Total Value
$882.16K
Shares Held After
721,832
% of Holdings
23.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
2,317
Price
$55.38
Total Value
$128.32K
Shares Held After
8,806,216
% of Holdings
0.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$28.02
Total Value
$210.15K
Shares Held After
26,250
% of Holdings
22.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
42,350
Price
$25.21
Total Value
$1.07M
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,416
Price
$120.00
Total Value
$169.92K
Shares Held After
33,552
% of Holdings
4.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
25,000
Price
$2.60
Total Value
$65.00K
Shares Held After
373,322
% of Holdings
6.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Climb Bio, Inc. (CLYM)
Brennan Aoife — Director
Shares
30,902
Price
$13.17
Total Value
$406.98K
Shares Held After
87,731
% of Holdings
26.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
154,768
Price
$21.14
Total Value
$3.27M
Shares Held After
221,278
% of Holdings
41.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
40,702
Price
$21.14
Total Value
$860.44K
Shares Held After
975,931
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
51,756
Price
$21.14
Total Value
$1.09M
Shares Held After
1,344,719
% of Holdings
3.7%
Showing 251–300 of 372 transactions (page 6 of 8)